SI3268493T1 - MRNA tumorski označevalci na osnovi polne krvi za napovedovanje raka prostate in postopki za odkrivanje le-teh - Google Patents
MRNA tumorski označevalci na osnovi polne krvi za napovedovanje raka prostate in postopki za odkrivanje le-tehInfo
- Publication number
- SI3268493T1 SI3268493T1 SI201631473T SI201631473T SI3268493T1 SI 3268493 T1 SI3268493 T1 SI 3268493T1 SI 201631473 T SI201631473 T SI 201631473T SI 201631473 T SI201631473 T SI 201631473T SI 3268493 T1 SI3268493 T1 SI 3268493T1
- Authority
- SI
- Slovenia
- Prior art keywords
- detecting
- methods
- same
- prostate cancer
- whole blood
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562132064P | 2015-03-12 | 2015-03-12 | |
| PCT/US2016/022004 WO2016145308A2 (en) | 2015-03-12 | 2016-03-11 | Whole blood based mrna markers for predicting prostate cancer and methods of detecting the same |
| EP16713202.6A EP3268493B1 (en) | 2015-03-12 | 2016-03-11 | Whole blood based mrna markers for predicting prostate cancer and methods of detecting the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3268493T1 true SI3268493T1 (sl) | 2022-04-29 |
Family
ID=55642872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201631473T SI3268493T1 (sl) | 2015-03-12 | 2016-03-11 | MRNA tumorski označevalci na osnovi polne krvi za napovedovanje raka prostate in postopki za odkrivanje le-teh |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20160304962A1 (sl) |
| EP (1) | EP3268493B1 (sl) |
| JP (1) | JP2018507702A (sl) |
| KR (1) | KR20170136525A (sl) |
| CN (1) | CN107567502A (sl) |
| CA (1) | CA2979226A1 (sl) |
| CY (1) | CY1125020T1 (sl) |
| DK (1) | DK3268493T3 (sl) |
| ES (1) | ES2905163T3 (sl) |
| HR (1) | HRP20220128T1 (sl) |
| HU (1) | HUE058025T2 (sl) |
| IL (1) | IL254119A0 (sl) |
| LT (1) | LT3268493T (sl) |
| MA (1) | MA45480A (sl) |
| PL (1) | PL3268493T3 (sl) |
| PT (1) | PT3268493T (sl) |
| RS (1) | RS62972B1 (sl) |
| SI (1) | SI3268493T1 (sl) |
| WO (1) | WO2016145308A2 (sl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3274476B1 (en) | 2015-03-25 | 2023-06-07 | The General Hospital Corporation | Digital analysis of circulating tumor cells in blood samples |
| EP3532642B1 (en) | 2016-10-27 | 2021-12-08 | The General Hospital Corporation | Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers |
| CN107338319A (zh) * | 2017-08-25 | 2017-11-10 | 天津艾至恩医疗科技有限公司 | 一种核苷酸引物及预测前列腺癌去势术预后的基因多态性检测试剂盒 |
| CN110760585B (zh) * | 2019-11-07 | 2022-12-09 | 深圳市华启生物科技有限公司 | 前列腺癌生物标志物及其应用 |
| CN111500728A (zh) * | 2020-05-13 | 2020-08-07 | 无锡市申瑞生物制品有限公司 | 检测人ar-v7及ar基因表达的引物探针组合物、试剂盒及检测方法 |
| WO2023220314A1 (en) * | 2022-05-12 | 2023-11-16 | Veracyte SD, Inc. | Prognosis and treatment of molecular subtypes of prostate cancer |
| KR20240022906A (ko) * | 2022-08-12 | 2024-02-20 | (주)맥시온 | 암 진단용 다중 바이오마커 및 이의 용도 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9146238B2 (en) * | 2008-04-16 | 2015-09-29 | The Johns Hopkins University | Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| WO2014028925A1 (en) * | 2012-08-17 | 2014-02-20 | Memorial Sloan-Kettering Cancer Center | Gene expression profile associated with prostate cancer |
| CA2907124C (en) * | 2013-03-15 | 2021-07-06 | Janssen Pharmaceutica Nv | Assay for predictive biomarkers |
-
2016
- 2016-03-11 DK DK16713202.6T patent/DK3268493T3/da active
- 2016-03-11 SI SI201631473T patent/SI3268493T1/sl unknown
- 2016-03-11 HR HRP20220128TT patent/HRP20220128T1/hr unknown
- 2016-03-11 MA MA045480A patent/MA45480A/fr unknown
- 2016-03-11 WO PCT/US2016/022004 patent/WO2016145308A2/en active Application Filing
- 2016-03-11 CN CN201680015329.2A patent/CN107567502A/zh active Pending
- 2016-03-11 CA CA2979226A patent/CA2979226A1/en not_active Abandoned
- 2016-03-11 HU HUE16713202A patent/HUE058025T2/hu unknown
- 2016-03-11 RS RS20220141A patent/RS62972B1/sr unknown
- 2016-03-11 KR KR1020177028155A patent/KR20170136525A/ko unknown
- 2016-03-11 EP EP16713202.6A patent/EP3268493B1/en active Active
- 2016-03-11 LT LTEPPCT/US2016/022004T patent/LT3268493T/lt unknown
- 2016-03-11 PL PL16713202T patent/PL3268493T3/pl unknown
- 2016-03-11 US US15/067,716 patent/US20160304962A1/en not_active Abandoned
- 2016-03-11 ES ES16713202T patent/ES2905163T3/es active Active
- 2016-03-11 JP JP2017548024A patent/JP2018507702A/ja active Pending
- 2016-03-11 PT PT167132026T patent/PT3268493T/pt unknown
-
2017
- 2017-08-23 IL IL254119A patent/IL254119A0/en unknown
-
2022
- 2022-02-21 CY CY20221100142T patent/CY1125020T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018507702A (ja) | 2018-03-22 |
| HUE058025T2 (hu) | 2022-06-28 |
| EP3268493B1 (en) | 2022-01-05 |
| US20160304962A1 (en) | 2016-10-20 |
| DK3268493T3 (da) | 2022-03-07 |
| WO2016145308A2 (en) | 2016-09-15 |
| CA2979226A1 (en) | 2016-09-15 |
| LT3268493T (lt) | 2022-03-10 |
| MA45480A (fr) | 2018-01-17 |
| KR20170136525A (ko) | 2017-12-11 |
| WO2016145308A3 (en) | 2016-10-13 |
| CY1125020T1 (el) | 2023-03-24 |
| PL3268493T3 (pl) | 2022-05-09 |
| RS62972B1 (sr) | 2022-03-31 |
| ES2905163T3 (es) | 2022-04-07 |
| PT3268493T (pt) | 2022-04-13 |
| CN107567502A (zh) | 2018-01-09 |
| IL254119A0 (en) | 2017-10-31 |
| EP3268493A2 (en) | 2018-01-17 |
| HRP20220128T1 (hr) | 2022-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201900856B (en) | Systems and methods for enhanced detection and quantification of analytes | |
| HK1248285A1 (zh) | 判定癌症狀態之方法及系統 | |
| IL254119A0 (en) | Blood-based mrna markers for prostate cancer prediction and methods for its detection | |
| GB201618485D0 (en) | Method of detecting tumour recurrence | |
| IL267302A (en) | Epigenetic markers and methods and measures related to them for the detection and management of certain types of cancer | |
| EP3524689C0 (en) | METHOD FOR PROGNOSIS OF BREAST CANCER PATIENTS | |
| DK3179393T3 (da) | Genexpressionsprofilalgoritme og -test til bestemmelse af prognosen for prostatakræft | |
| HUE053281T2 (hu) | Rák kimutatási rendszerek és eljárások | |
| IL253160B (en) | Cancer markers and methods of using them | |
| IL253710A0 (en) | Biomarkers for pancreatic cancer, and kits and methods to detect them | |
| HK1251414A1 (zh) | 用於檢測癌症復發風險的方法和組合物 | |
| IL251440B (en) | Methods and systems for identifying analytes | |
| EP3374524A4 (en) | PROCESS FOR DETECTION OF 5-HYDROXYMETHYLCYTOSINE AND FOR DIAGNOSIS OF CANCER | |
| HK1220253A1 (zh) | 診斷前列腺癌症的方法 | |
| MA40636A (fr) | Procédés pour détecter le cancer de la prostate | |
| EP3302479A4 (en) | TUMOR BIOMARKERS AND USE THEREOF | |
| EP3341496A4 (en) | METHODS OF DETECTION OF A CANCER RECIDIVE | |
| GB201718352D0 (en) | Devices and methods for detection of biomarkers | |
| SG11201708795TA (en) | Analyte detection and methods therefor | |
| GB201619808D0 (en) | Biomarkers for the prognosis and diagnosis of cancer | |
| EP3298172A4 (en) | Determining risk of prostate cancer recurrence | |
| GB201416868D0 (en) | Mass spectral analysis of urine and other bodily fluids for the detection of cancer biomarkers | |
| EP3183366A4 (en) | Systems and methods of detecting solid tumor cancer | |
| HK1202314A1 (en) | Markers for detecting bowel cancer and use thereof | |
| GB201508185D0 (en) | Methods of detecting and predicting cancer |